These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8184812)

  • 21. [A comparison between lovastatin and pravastatin--effects on lipids, sleep and quality of life in primary hyperlipidemia].
    Tonstad S; Gørbitz C; Ose L; Malt UF
    Tidsskr Nor Laegeforen; 1994 Aug; 114(19):2262-4. PubMed ID: 7992293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
    Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients.
    Am J Cardiol; 1993 Nov; 72(14):1031-7. PubMed ID: 8213583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers.
    Harrison RW; Ashton CH
    Br J Clin Pharmacol; 1994 Mar; 37(3):231-6. PubMed ID: 8198930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pravastatin in patients with cardiac risk factors. Effects of pravastatin in patients with total serum cholesterol concentrations of 200 to 300 mg/dl (5.2 to 7.8 mmol/l) and two additional atherosclerosis risk factors. Pravastatin Multinational Study Group for Cardiac Risk Patients].
    Fortschr Med; 1994 Feb; 112(5):57-64. PubMed ID: 8163252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Randomized, double-blind comparative study between pravastatin and lovastatin. Evaluation of efficacy and safety].
    Giannini SD; Bertolami MC; Schölz J; Faludi AA; Forti N; Diament J
    Arq Bras Cardiol; 1994 Oct; 63(4):327-32. PubMed ID: 7771954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of clinical trials comparing HMG-CoA reductase inhibitors.
    Illingworth DR; Tobert JA
    Clin Ther; 1994; 16(3):366-85; discussion 365. PubMed ID: 7923304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.
    Davidson M; McKenney J; Stein E; Schrott H; Bakker-Arkema R; Fayyad R; Black D
    Am J Cardiol; 1997 Jun; 79(11):1475-81. PubMed ID: 9185636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.
    Mallon PW; Miller J; Kovacic JC; Kent-Hughes J; Norris R; Samaras K; Feneley MP; Cooper DA; Carr A
    AIDS; 2006 Apr; 20(7):1003-10. PubMed ID: 16603852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance.
    Roth T; Richardson GR; Sullivan JP; Lee RM; Merlotti L; Roehrs T
    Clin Cardiol; 1992 Jun; 15(6):426-32. PubMed ID: 1617822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of therapeutic interchange from pravastatin to lovastatin in a Veterans Affairs Medical Center.
    Patel RJ; Gray DR; Pierce R; Jafari M
    Am J Manag Care; 1999 Apr; 5(4):465-74. PubMed ID: 10387386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lovastatin versus bezafibrate: efficacy, tolerability, and effect on urinary mevalonate.
    Beil FU; Schrameyer-Wernecke A; Beisiegel U; Greten H; Karkas JD; Liou R; Alberts AW; Eckardt HG; Till AE
    Cardiology; 1990; 77 Suppl 4():22-32. PubMed ID: 2073669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).
    Smith DG; McBurney CR
    Pharmacoeconomics; 2003; 21 Suppl 1():13-23. PubMed ID: 12648031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)].
    Golay A; Lehmann T; James R; Pometta D
    Schweiz Med Wochenschr; 1993 Aug; 123(33):1553-8. PubMed ID: 8372340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin.
    Pan HY; DeVault AR; Wang-Iverson D; Ivashkiv E; Swanson BN; Sugerman AA
    J Clin Pharmacol; 1990 Dec; 30(12):1128-35. PubMed ID: 2125605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia.
    Hunninghake DB; Stein EA; Dujovne CA; Harris WS; Feldman EB; Miller VT; Tobert JA; Laskarzewski PM; Quiter E; Held J
    N Engl J Med; 1993 Apr; 328(17):1213-9. PubMed ID: 8464431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.